There are 2789 resources available
1303P - A clinical variable based nomogram could predict survival for NSCLC patients receiving atezolizumab
Presenter: Xiaoling Shang
Session: ePoster Display
1304P - Interleukin-6 (IL-6) as a potential predictive marker and a desensitizer for immunotherapy response in non-small cell lung cancer
Presenter: Yan Wang
Session: ePoster Display
1305P - Peripheral low-density neutrophils in the response to immunotherapy in untreated non-small cell lung cancer
Presenter: Hugo Arasanz
Session: ePoster Display
1231P - Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy
Presenter: James Chih-Hsin Yang
Session: ePoster Display
1232P - Understanding the diagnostic and treatment landscape in EGFRm advanced non-small cell lung cancer (aNSCLC) patients with exon 20 insertion mutations (Ex20ins)
Presenter: Hollie Bailey
Session: ePoster Display
1233P - EGFR-TKIs compared with radiotherapy for patients of stage IV lung adenocarcinoma with EGFR mutation
Presenter: Yuxiang Wang
Session: ePoster Display
1234P - Impact of radiotherapy pattern on the prognosis of stage IV lung adenocarcinomas harboring EGFR mutations
Presenter: Yingyun Zhang
Session: ePoster Display
1235P - Comparative study between two 17-gray fractions versus thirteen 39-gray fractions palliative thoracic radiotherapy in advanced non-small cell lung carcinoma
Presenter: Syeda Tasmia
Session: ePoster Display
1236P - Poziotinib in NSCLC harbouring EGFR or HER2 exon 20 insertion mutation
Presenter: Arsela Prelaj
Session: ePoster Display
1237P - Gut microbiome profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
Presenter: Woraseth Saifon
Session: ePoster Display